Quick Answer
CVS HEALTH Corp reported Operating Income Loss of $4.66 billion for the year ending 2025.
- CVS HEALTH Corp showed a decrease of -45.3% in Operating Income Loss from 2024 to 2025.
- This data is from CVS HEALTH Corp's annual report (Form 10-K), filed with the SEC on February 10, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2013: $2.22 billion | Q1 2014: $2.02 billion | Q2 2014: $2.21 billion | Q3 2014: $2.25 billion | Q4 2014: $2.32 billion | Q1 2015: $2.13 billion | Q2 2015: $2.26 billion | Q3 2015: $2.33 billion | Q4 2015: $2.73 billion | Q1 2016: $2.19 billion | Q2 2016: $2.36 billion | Q3 2016: $2.82 billion | Q4 2016: $3.00 billion | Q1 2017: $1.80 billion | Q2 2017: $2.12 billion | Q3 2017: $2.50 billion | Q4 2017: $3.11 billion | Q1 2018: $2.00 billion | Q2 2018: -$1.37 billion | Q3 2018: $2.57 billion | Q4 2018: $824.00 million | Q1 2019: $2.69 billion | Q2 2019: $3.33 billion | Q3 2019: $2.93 billion | Q4 2019: $3.04 billion | Q1 2020: $3.46 billion | Q2 2020: $4.68 billion | Q3 2020: $3.25 billion | Q1 2021: $3.58 billion | Q2 2021: $4.33 billion | Q3 2021: $3.06 billion | Q1 2022: $3.55 billion | Q2 2022: $4.67 billion | Q3 2022: -$3.92 billion | Q1 2023: $3.45 billion | Q2 2023: $3.23 billion | Q3 2023: $3.69 billion | Q1 2024: $2.27 billion | Q2 2024: $3.05 billion | Q3 2024: $832.00 million | Q1 2025: $3.37 billion | Q2 2025: $2.38 billion | Q3 2025: -$3.21 billion.
- Over the full 18 years of available data (2008 to 2025), CVS HEALTH Corp's Operating Income Loss has declined by 22.9%.
- Historical annual values: Fiscal year 2025: $4.66 billion | Fiscal year 2024: $8.52 billion | Fiscal year 2023: $13.74 billion | Fiscal year 2022: $7.95 billion | Fiscal year 2021: $13.31 billion | Fiscal year 2020: $13.91 billion | Fiscal year 2019: $11.99 billion | Fiscal year 2018: $4.02 billion | Fiscal year 2017: $9.54 billion | Fiscal year 2016: $10.39 billion | Fiscal year 2015: $9.48 billion | Fiscal year 2014: $8.80 billion | Fiscal year 2013: $8.04 billion | Fiscal year 2012: $7.21 billion | Fiscal year 2011: $6.33 billion | Fiscal year 2010: $6.14 billion | Fiscal year 2009: $6.43 billion | Fiscal year 2008: $6.05 billion.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: